VANCOUVER, B.C., Nov. 11 /PRNewswire-FirstCall/ -- The following was released today by Robert Kramer, CEO of Current Technology Corporation (BULLETIN BOARD: CRTCF) :
Current Technology (the "Company") reports that Gromark Consumers Enterprise Pte. Ltd. ("Gromark") has opened its first Asian ETG Treatment Center in Singapore. Gromark, the Company's exclusive ElectroTrichoGenesis ("ETG") distributor for the Republic of Singapore, Malaysia and the Hong Kong Special Administrative Region, chose Camden Medical Centre, Singapore's premier medical office, wellness and preventative healthcare facility, for its flagship location. The Camden Medical Centre will serve as both a commercial venue for ETG Treatments and a training center for Asia. "We are delighted Gromark has chosen such a prestigious location," states CEO Robert Kramer. "It symbolizes the importance they place on establishing ETG throughout Asia."
As further evidence of the growing importance of its relationship with Gromark, the Company is pleased to announce the appointment of Gromark's Medical Director, Dr. Eugene Hong C.J., to its Medical and Scientific Advisory Board. Dr. Hong earned an MBBS, Bachelor Medicine and Surgery from Monash University (Australia) and is a Diplomate of the American Board of Anti-Aging Medicine. "Dr. Hong brings a unique perspective to the Advisory Board," continues Kramer. "In addition to his medical credentials, he has extensive experience in product development and niche marketing in the health care industry."
About Gromark
In business for over 20 years and with strong regional business interests and networks throughout Asia and the Indian sub-continent, Gromark is based in Singapore. Gromark commenced business as a trading company representing such international brands as British American Tobacco and Moet Hennessy Asia. In recent years Gromark has evolved form general trading to a focus on health and beauty.
About ETG and Current Technology Corporation
Current Technology Corporation is the developer of ETG (ElectroTrichoGenesis) a patented electrotherapeutic device that provides a clinically proven medical treatment for hair loss. ETG treatment centers are presently available in eleven countries around the world and will soon be introduced to Malaysia and Hong Kong. ETG has been shown to be useful in preventing or reducing hair loss in women undergoing CMF chemotherapy for breast cancer.
Current Technology CorporationCONTACT: Robert Kramer of Current Technology Corporation, 800-661-4247,or +1-604-684-2727, or bob@currentech.com; or investors, Richard Hannon ofPolestar Communications, 1-866-858-4100, for Current Technology Corporation
Web site: http://www.etgtreatment.com/